PHS
IOVA icon

PFM Health Sciences’s Iovance Biotherapeutics IOVA Stock Holding History

PFM Health Sciences’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-132,152
Closed -$440K – 66
2025
Q1 		$440K Hold
132,152
– – 0.03% 64
2024
Q4 		$978K Hold
132,152
– – 0.07% 77
2024
Q3 		$1.24M Sell
132,152
-20,643
-14% -$196K 0.07% 71
2024
Q2 		$1.23M Sell
152,795
-157,959
-51% -$1.69M 0.07% 74
2024
Q1 		$4.61M Buy
+310,754
New +$3.62M 0.23% 69
2023
Q3 		– Sell
-946,305
Closed -$6.66M – 79
2023
Q2 		$6.66M Buy
946,305
+804,250
+566% +$5.76M 0.27% 68
2023
Q1 		$868K Buy
142,055
+128,718
+965% +$888K 0.04% 77
2022
Q4 		$85.2K Buy
+13,337
New +$104K ﹤0.01% 89
2020
Q4 		– Sell
-381,990
Closed -$15.2M – 94
2020
Q3 		$12.6M Buy
+381,990
New +$11.7M 0.67% 56

Other funds holding IOVA

MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return